The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
The correlation between the costs and clinical benefits of PD-1/PD-L1 inhibitors in malignant tumors: An evaluation based on ASCO and ESMO frameworks
|
---|---|
Published in |
Frontiers in Pharmacology, February 2023
|
DOI | 10.3389/fphar.2023.1114304 |
Pubmed ID | |
Authors |
Shen Lin, Yaping Huang, Liangliang Dong, Meiyue Li, Yahong Wang, Dian Gu, Wei Wu, Dongni Nian, Shaohong Luo, Xiaoting Huang, Xiongwei Xu, Xiuhua Weng |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 16 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 3 | 19% |
Unspecified | 2 | 13% |
Student > Bachelor | 2 | 13% |
Student > Ph. D. Student | 1 | 6% |
Other | 1 | 6% |
Other | 0 | 0% |
Unknown | 7 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 2 | 13% |
Biochemistry, Genetics and Molecular Biology | 2 | 13% |
Nursing and Health Professions | 2 | 13% |
Medicine and Dentistry | 2 | 13% |
Agricultural and Biological Sciences | 1 | 6% |
Other | 0 | 0% |
Unknown | 7 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2023.
All research outputs
#20,807,832
of 23,415,749 outputs
Outputs from Frontiers in Pharmacology
#10,705
of 16,943 outputs
Outputs of similar age
#255,817
of 328,630 outputs
Outputs of similar age from Frontiers in Pharmacology
#500
of 853 outputs
Altmetric has tracked 23,415,749 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,943 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,630 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 853 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.